The CEO Behind One of Cathie Wood's Favorite Stocks

The video discusses NBT's focus on integrating genetics into mainstream healthcare to improve outcomes globally. It highlights the company's decade-long investment in genetic information and its transformative potential. The discussion includes significant investments from SoftBank and the expansion of infrastructure to scale operations. The impact of COVID-19 on the business is addressed, noting a temporary revenue drop but a positive long-term outlook for recovery and growth.

What is the primary focus of NBT in the context of healthcare?

• Training healthcare professionals

• Developing new pharmaceuticals

• Integrating genetics into mainstream medical care

• Building hospitals worldwide

Which major investor has contributed over a billion dollars to NBT?

• Morgan Stanley

• JP Morgan

• SoftBank

• Goldman Sachs

What is one of the key strategies NBT is using to scale its operations?

• Building a tech infrastructure

• Focusing on local markets only

• Reducing the workforce

• Increasing product prices

Where is NBT establishing a new production facility to improve service delivery?

• Silicon Valley, California

• Boston, Massachusetts

• Austin, Texas

• Research Triangle Park, North Carolina

How did the COVID-19 pandemic initially affect NBT's revenue?

• Revenue doubled

• Revenue remained stable

• Revenue was cut in half

• Revenue increased slightly